The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

G.H. Gislason; J.N. Rasmussen; S.Z. Abildstrom; S. Rasmussen; T.K. Schramm; F. Folke; M.L. Hansen; Lars Valeur Køber; M. Madsen; C. Torp-Pedersen

The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom, S. Rasmussen, T.K. Schramm, F. Folke, M.L. Hansen, Lars Valeur Køber, M. Madsen, C. Torp-Pedersen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Circulation
Issue number	16
Pages (from-to)	3271-
ISSN	0009-7322
Publication status	Published - 2007
Event	The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure - Duration: 29 Nov 2010 → …

Conference

Conference	The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure
Period	29/11/2010 → …

Cite this

The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. / Gislason, G.H.; Rasmussen, J.N.; Abildstrom, S.Z.; Rasmussen, S.; Schramm, T.K.; Folke, F.; Hansen, M.L.; Køber, Lars Valeur ; Madsen, M.; Torp-Pedersen, C.

In: Circulation, No. 16, 2007, p. 3271-.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Gislason, G.H. ; Rasmussen, J.N. ; Abildstrom, S.Z. ; Rasmussen, S. ; Schramm, T.K. ; Folke, F. ; Hansen, M.L. ; Køber, Lars Valeur ; Madsen, M. ; Torp-Pedersen, C. / The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. In: Circulation. 2007 ; No. 16. pp. 3271-.

@article{f6124ad088e011df928f000ea68e967b,

title = "The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure",

author = "G.H. Gislason and J.N. Rasmussen and S.Z. Abildstrom and S. Rasmussen and T.K. Schramm and F. Folke and M.L. Hansen and K{\o}ber, {Lars Valeur} and M. Madsen and C. Torp-Pedersen",

note = "J0 Udgivelsesdato: 2007 Volumne: 116; The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure ; Conference date: 29-11-2010",

year = "2007",

language = "English",

pages = "3271--",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "16",

}

TY - ABST

T1 - The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

AU - Gislason, G.H.

AU - Rasmussen, J.N.

AU - Abildstrom, S.Z.

AU - Rasmussen, S.

AU - Schramm, T.K.

AU - Folke, F.

AU - Hansen, M.L.

AU - Køber, Lars Valeur

AU - Madsen, M.

AU - Torp-Pedersen, C.

N1 - J0 Udgivelsesdato: 2007 Volumne: 116

PY - 2007

Y1 - 2007

M3 - Conference abstract in journal

SP - 3271-

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

T2 - The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

Y2 - 29 November 2010

ER -